TERT and nephrotic syndrome, type 4: In contrast to what was observed with TERT amplification, the concurrence of TPM with TERT amplification or RAS mutations results in the appearance of statistically significant associations with clinical-pathological traits of poor prognosis (vascular invasion, DMs at diagnosis and/or during follow-up, and metachronous DMs) that with TPM per se were not significant.